Anatomic Stage II Breast Cancer AJCC v8 trials recruiting in Arizona

All Anatomic Stage II Breast Cancer AJCC v8 trials nationally

Cities in Arizona

Recruiting trials in Arizona

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Tucson
• Breast Cancer, Reasoning, and Activity Intervention
  NCT04816006 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: Female · Arizona: Phoenix
• Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
  NCT05417867 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · Arizona: Scottsdale
• Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
  NCT06635980 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · Arizona: Scottsdale
• ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
  NCT06876714 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Phoenix
• Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
  NCT05929768 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Kingman, Phoenix